Anbio Biotechnology (NNNN)

NasdaqGM: NNNN · Prix en temps réel · USD

6.89

-0.41 (-5.62%)

À la clôture : Sep 02, 2026, 3:59 PM

6.94

+1.31%

Après-Bourse: 7:58 PM

Alerte

Alert

Le cours, les chiffres clés et les dernières actualités, au même endroit.

-5.62% (1D)

Cours acheteur	11.55
Capitalisation boursière	301M
Chiffre d’affaires (ttm)	8.65M
Résultat net (ttm)	6.4M
	0.00
	0.14
	48.93
	n/a
P/B (ttm)	9.97
P/S (ttm)	34.77
Date des résultats	n/a

Cours vendeur	9.89
Volume	254,790
Volume moy. (20D)	89,030
Ouverture	7.32
Clôture précédente	7.30
Fourchette du jour	6.80 - 7.36
Intervalle de 52 semaines	6.61 - 51.33
Analyste	n/a
Objectif de prix	n/a
Dividendes	n/a
Date ex-dividende	n/a

À propos de NNNN

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over...

[En savoir plus]

Industrie Medical Instruments & Supplies

Secteur Healthcare

Date d’introduction Feb 19, 2025

Employés 27

Bourse NasdaqGM

Symbole boursier NNNN

Site web https://www.anbiobiotechnology.com

Profil complet de l’entreprise

Performance financière

En 2025, le chiffre d’affaires de Anbio Biotechnology s’élevait à 8.65M, soit une hausse de 5.64% par rapport aux 8.19M de l’année précédente. Le bénéfice s’élevait à 6.4M, soit une hausse de 169.86%.

États financiers

Surprise sur les résultats

Anbio Biotechnology a publié ses résultats trimestriels le Invalid Date :

Chiffre d’affaires de n/a est inférieur aux estimations de $0, avec NaN% croissance en glissement annuel.
EPS de est inférieur aux estimations de , avec NaN% croissance en glissement annuel.

Pourquoi le prix a changé

Actualités

3 mois il y a · Simply Wall St.

US Undiscovered Gems To Watch In May 2026

The United States market has shown robust performance recently, climbing 1.8% in the last week and up 28% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In ...

3 mois il y a · Simply Wall St.

Discover 3 Undiscovered Gems in the US Market

The United States market has experienced a notable rise, climbing 1.8% in the last week and up 28% over the past year, with earnings projected to grow by 17% annually. In such a robust environment, id...

3 mois il y a · Simply Wall St.

Uncovering US Market's 3 Undiscovered Gems With Potential

The United States market has experienced a notable rise, with a 1.3% increase over the last week and a substantial 28% gain in the past year, while earnings are projected to grow by 17% annually in th...

3 mois il y a · Simply Wall St.

Discovering US Undiscovered Gems In May 2026

Over the last 7 days, the United States market has remained flat, yet it has seen a remarkable increase of 27% over the past year with earnings forecasted to grow by 17% annually. In such a dynamic en...

3 mois il y a · Simply Wall St.

Undiscovered Gems in the US Market May 2026

In the last week, the United States market has stayed flat despite being up 27% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks with stron...

Page 1 de 2

Anbio Biotechnology (NNNN)